Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:administeredBy |
oral
intravenous |
| gptkbp:approvedBy |
gptkb:FDA
1983 |
| gptkbp:ATCCode |
L04AD01
|
| gptkbp:brand |
gptkb:cyclosporine
|
| gptkbp:chemicalFormula |
C62H111N11O12
|
| gptkbp:discoveredIn |
1970s
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sandimmune
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Novartis
|
| gptkbp:mechanismOfAction |
immunosuppressant
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
hypertension
tremor nephrotoxicity hirsutism |
| gptkbp:usedFor |
prevention of organ transplant rejection
treatment of autoimmune diseases |
| gptkbp:bfsParent |
gptkb:cyclosporine
gptkb:Sandoz_Laboratories |
| gptkbp:bfsLayer |
6
|